Cite
HARVARD Citation
Yanai, H. et al. (2019). Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study. Journal of Crohn's and colitis. pp. 539-540. [Online].